PCMC
MRVI icon

Planning Capital Management Corporation’s Maravai LifeSciences MRVI Stock Holding History

Planning Capital Management Corporation’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$17.2K Hold
2,070
– – 0.01% 334
2024
Q2 		$14.8K Hold
2,070
– – 0.01% 348
2024
Q1 		$17.9K Buy
+2,070
New +$14K 0.01% 311

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Planning Capital Management Corporation's MRVI Position: Q3 2024 in Review

Planning Capital Management Corporation held its Maravai LifeSciences (MRVI) position steady in Q3 2024 at 2,070 shares worth $17.2K. The position accounts for 0.01% of the portfolio, ranked #334.

Planning Capital Management Corporation first reported a position in MRVI in Q1 2024 and has held it in 3 quarters since. The position peaked at $17.9K in Q1 2024. 217 funds tracked by Wall St. Rank hold MRVI as of Q3 2024.

  • Planning Capital Management Corporation held 2,070 shares of Maravai LifeSciences worth $17.2K as of Q3 2024.
  • Planning Capital Management Corporation left its Maravai LifeSciences share count unchanged in Q3 2024.
  • Maravai LifeSciences made up 0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #334 holding.
  • Planning Capital Management Corporation first reported a position in Maravai LifeSciences in Q1 2024 and has held it in 3 quarters since.
  • Planning Capital Management Corporation's Maravai LifeSciences position peaked at $17.9K in Q1 2024.
  • 217 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.